Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-01-19 @ 8:21 AM
Study NCT ID:
NCT03537157
Status:
TERMINATED
Last Update Posted:
2021-09-27
First Post:
2018-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention
Sponsor:
Alfasigma S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RETIPC/01/17
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |